Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK1 | P23458 | 19/20 | 1.00 |
| ▸ | JAK2 | O60674 | 14/20 | 1.00 |
| ▸ | JAK3 | P52333 | 2/20 | 0.73 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29394800 | 1.00 | JAK1 (1.00) | JAK1JAK2JAK3KCNH2 | |
| SCHEMBL18662647 | 1.00 | JAK1 (1.00) | JAK1JAK2JAK3KCNH2 | |
| SCHEMBL18662634 | 0.95 | JAK1 (1.00) | JAK1JAK2 | |
| SCHEMBL26067059 | 0.95 | JAK1 (1.00) | JAK1JAK2 | |
| SCHEMBL29392366 | 0.95 | JAK1 (1.00) | JAK1JAK2 | |
| SCHEMBL18662708 | 0.94 | JAK1 (1.00) | JAK1JAK2JAK3KCNH2 | |
| SCHEMBL25409544 | 0.94 | JAK1 (1.00) | JAK1JAK2JAK3KCNH2 | |
| SCHEMBL18662675 | 0.93 | JAK1 (1.00) | JAK1JAK2JAK3KCNH2 | |
| SCHEMBL25407379 | 0.93 | JAK1 (1.00) | JAK1JAK2JAK3KCNH2 | |
| SCHEMBL25407076 | 0.92 | JAK1 (1.00) | JAK1JAK2JAK3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3353168-B1 | COMPOUNDS AND METHODS FOR INHIBITING JAK | DIZAL JIANGSU PHARMACEUTICAL CO LTD (CN) | 2023-08-30 | — | — | EP | claimed |
| CN-111848586-A | Compounds and methods for inhibiting JAK | 迪哲（江苏）医药有限公司 | 2020-10-30 | — | — | CN | claimed |
| EP-3353168-B1 | COMPOUNDS AND METHODS FOR INHIBITING JAK | DIZAL JIANGSU PHARMACEUTICAL CO LTD (CN) | 2023-08-30 | — | — | EP | disclosed |